Simona Dalin
About Simona Dalin
Simona Dalin is a postdoctoral researcher currently affiliated with Harvard Medical School and Dana-Farber Cancer Institute. Her research focuses on chemotherapy resistance, utilizing both computational and experimental methods.
Work at Broad Institute
Simona Dalin has been a Postdoctoral Researcher at the Broad Institute of MIT and Harvard since 2019. In this role, she focuses on studying chemotherapy resistance by utilizing both computational and experimental tools. Her research contributes to understanding the genomic structural variations that affect treatment outcomes in cancer patients. Collaborating with notable researchers such as Rameen Beroukhim and Gaddy Getz, Dalin is involved in significant projects that aim to advance cancer treatment methodologies.
Current Position at Dana-Farber Cancer Institute
Simona Dalin serves as a Postdoctoral Researcher at the Dana-Farber Cancer Institute, a position she has held since 2019. Her work at Dana-Farber emphasizes the exploration of chemotherapy resistance mechanisms in cancer. Through her research, she aims to identify the genetic factors that contribute to treatment efficacy and patient outcomes. Dalin collaborates closely with other researchers in the institute to enhance the understanding of cancer genomics.
Education and Expertise
Simona Dalin earned her PhD in Biology from the Massachusetts Institute of Technology (MIT), where she studied from 2013 to 2019. Prior to that, she completed her Bachelor of Science in Biology and Mathematics at Brandeis University from 2007 to 2011. Her educational background provides a strong foundation in both biological sciences and quantitative analysis, which she applies in her research on chemotherapy resistance.
Previous Research and Teaching Experience
Before her current roles, Simona Dalin gained extensive experience in various research and teaching positions. She worked as a Research Technician at MIT from 2011 to 2013 and served as a Teaching Assistant at MIT in 2015 and again in 2017. Additionally, she was an Undergraduate Teaching Assistant at Brandeis University from 2010 to 2011. Her early career also included a role as a Laboratory Technician at the FDA in 2007 and a Research Experience for Undergraduates at Towson University in 2009.
Research Focus and Collaborations
Simona Dalin's research primarily investigates the contribution of genomic structural variation to chemotherapy resistance. She collaborates with other researchers at Dana-Farber Cancer Institute and the Broad Institute, including Rameen Beroukhim and Gaddy Getz. This collaborative approach enhances the depth and impact of her research, aiming to uncover critical insights into cancer treatment challenges.